Jill Durocher
Increasing Women’s Choices in Medical Abortion: A Study of Misoprostol 400 microg Swallowed Immediately or Held Sublingually Following 200 mg Mifepristone
- Published
- June 30th, 2009
- Type
- Publication
- Topic
- Medical Abortion
- Authors
- Akın, A., Dabash, R., Dilbaz, B, Aktun, H., Dursun, P., Kıran, S., Aksan, G., Dogan, B., Winikoff, B.
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75; doi:10.1080/13625180902916020
This article reports on results of a clinical trial evaluating two routes of misoprostol administration following mifepristone for early medical abortion. For gestations through 56 days since last menstrual period 400mcg of oral misoprostol performed better than a 400mcg sublingual dose when following 200mg mifepristone although not significantly so.